Andrew Spargo, PharmD, MBA, MS

Sr. Principal Scientist
Eli Lilly and Company

Poster(s):

• (367) Healthcare costs associated with timely diagnosis of mild cognitive impairment and Alzheimer's Disease
  Wednesday, October 29, 2025